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UPLC–MSAbstract Natural products from wild and medicinal plants, either in the form of crude extracts or
pure compounds provide unlimited opportunities for new drug leads owing to the unmatched avail-
ability of chemical diversity. In the present study, the cytotoxic potential of crude ethanolic extract
of Ochradenus arabicus was analyzed by MTT cell viability assay in MCF-7 adenocarcinoma breast
cancer cells. We further investigated its effect against oxidative stress induced by anticancer drug
doxorubicin. In addition, Ultra Performance Liquid Chromatography–Mass Spectrometry
(UPLC–MS) based chromatographic proﬁling of crude extract of O. arabicus was performed.
The MTT assay data showed that the extract is moderately toxic to the MCF-7 cells. However,
its treatment alone does not induce oxidative stress while doxorubicin increases the level of
oxidative stress in MCF-7 cells. Whereas, simultaneous treatment of plant extract and doxorubicin
signiﬁcantly (p< 0.05) decreased the level of intracellular reactive oxygen species (ROS) and lipid
peroxidation while an increase in the reduced glutathione and superoxide dismutase activity was
observed in time and dose dependent manner. Hence, our ﬁnding conﬁrmed cytotoxic and
230 M.A. Ali et al.antioxidant potential of crude extract of O. arabicus in MCF-7 cells. However, further investiga-
tions on O. arabicus as a potential chemotherapeutic agent are needed. The analysis of bioactive
compounds present in the plant extracts involving the applications of common phytochemical
screening assays such as chromatographic techniques is discussed.
ª 2015 The Authors. Production and hosting by Elsevier B.V. on behalf of King Saud University. This is
an open access article under theCCBY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Cancer (a leading cause of death worldwide) is a group of dis-
eases characterized by the uncontrolled growth and spread of
abnormal cells. Breast cancer ranks second as a cause of cancer
death in women (Stewart and Wild, 2014; American Cancer
Society, 2014). There has long been standing interest in the
identiﬁcation of natural products for the treatment of various
diseases for thousands of years. Natural products possess
immense pharmacological signiﬁcance in the development of
drugs (Dixon et al., 2007; Baker et al., 2007; Harvey, 2008)
including cancer (Graham et al., 2000; Figueroa-Herna´ndez
et al., 2005; Madhuri and Pandey, 2009; Tan et al., 2011;
Newman and Cragg, 2012), and were discovered through plant
bioprospecting (Mann, 2002). Chemotherapy and radio-
therapy are highly effective methods of cancer treatment but
these methods exert severe side effects (Qi et al., 2010). Hence,
the identiﬁcation of novel natural products that possess better
effectiveness against cancer, but less harmful effects has
become desirable (Lachenmayer et al., 2010), and therefore,
natural products are continuously being explored worldwide.
A body of clinical and experimental evidence suggests that
oxidative stress is implicated in the onset and progression of
many health problems (Nakabeppu et al., 2004; Hybertson
et al., 2011). The imbalance between antioxidant defense and
oxidant production in cells may affect signaling pathways for
biologic processes and disrupt cellular function. Reactive
oxygen species (ROS) are generated as by-products of cellular
metabolism which are responsible for the alteration of macro-
molecules (Shieh et al., 2010). Dietary factors and natural
antioxidants that reduce the impact of ROS can protect
DNA damage and thus reduce the risk of cancers (Ke et al.,
2013). The ﬂoral elements of unique arid plant biodiversity
of Saudi Arabia are being practiced in folk medicine since
ancient times (Rahman et al., 2004). Plants that grow under
harsh desert stress conditions produced a high concentration
of secondary metabolites that impart a wide range of pharma-
cological effects (Harlev et al., 2012).
Earlier phytochemical investigations on the members of
Resedaceae such as Caylusea, Reseda and Ochradenus reveals
kaempferol, quercetin, isorhamnetin and luteolin as a major
ﬂavonoid glycosides (Barakat et al., 1991; Cristea et al.,
2003; Moiteiro et al., 2008; Marques et al., 2009; Berrehal
et al., 2010; Villela et al., 2011). The use of extracts of members
of the genus Ochradenus in folk medicine (Nawash and
Al-Horani, 2011), antibacterial (Abutbul et al., 2005), anti-
malarial (Sathiyamoorthy et al., 1999) and anticancer activity
(Thoppil et al., 2013) has previously been reported. Ochrade-
nus arabicus Chaudhary, Hillc. & A.G.Mill., is a shrub, dis-
tributed in desert regions of the Middle East i.e. Saudi
Arabia, Yemen, Oman and UAE (Chaudhary, 1999). The
biological activity and phytochemical screening of O. arabicusis lacking. Hence, in continuation of our efforts to study the
wild plants from desert regions, the present study aims to
unravel the cytotoxic and antioxidant potential against
MCF-7 adenocarcinoma breast cancer cells in vitro and chro-
matographic proﬁling of ethanolic extract of O. arabicus.2. Materials and methods
2.1. Plant material and preparation of crude extracts
The plant material of O. arabicus was collected from wild habi-
tat during plant explorations in Wadi Hanifa, Riyadh (Saudi
Arabia). The taxonomic identiﬁcation was conﬁrmed through
consultation of Flora of Saudi Arabia (Chaudhary, 1999). The
collected plant materials were rinsed thoroughly with tap water
to remove extraneous contaminants and cut into small pieces,
oven-dried at 50 C until stability of dry weight was observed,
and then grounded into powder form with an electric-grinder.
Crude extract was prepared by macerating the powdered plant
material (1000 g) in 95% ethanol at room temperature for one
week. The OA (O. arabicus) extracts were then ﬁltered and the
volume of the ﬁltrate was reduced using rotary evaporator at
low temperature and pressure. The crude extract was weighed
and stored at 20 C until used.
2.2. Cell culture methods
The human breast adenocarcinoma cells (MCF-7) procured
from ATCC (Rockville, MD, USA) were used in this study.
The cells were cultured in a humid environment at 37 C and
5% CO2 in a cell culture medium called minimum essential
medium (MEM, Invitrogen, USA) supplemented with 15%
fetal bovine serum (FBS) and 1% penicillin/streptomycin
(Invitrogen, USA). At 85–90% conﬂuence, cells were harvest-
ed using 0.25% trypsin/EDTA solution and sub-cultured into
6-well plate or 96-well plate according to the requirement of
experiments.
2.3. Cytotoxicity assay
The 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bro-
mide (MTT) colorimetric assay developed by Mosmann (1983)
with modiﬁcation was used to screen the cytotoxic activity.
Brieﬂy, the MCF-7 cells (1 · 104 cells/well) were grown for
overnight in 96-well ﬂat bottom culture plates. The crude
ethanolic extract of O. arabicus was initially dissolved in
dimethyl sulfoxide (DMSO) to prepare a stock solution of
100 mg/ml. Then, it was further diluted into 1.0 mg/ml by add-
ing complete cell culture medium, and serially diluted 2-fold
with same medium to obtain the working solutions of six con-
centrations i.e. 1.0 mg/ml, 0.50 mg/ml, 0.25 mg/ml, 0.12 mg/ml,
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above concentrations of O. arabicus extract for 24 h. In addi-
tion, negative/vehicle control, and 50 lM doxorubicin (Sigma
Aldrich, St. Louis, MO, USA) as positive control were also
used for comparison. After the completion of desired treat-
ment, 10 ll of MTT reagent (Invitrogen, USA) prepared in
5.0 mg/ml Phosphate Buffered Saline (PBS) was added to each
well and further incubated for 3 h at 37 C. Finally, medium
with MTT solution was removed, and 200 ll of DMSO (Sigma
Aldrich, St. Louis, MO, USA) was added to each well and
further incubated for 20 min. The optical density (OD) of each
well was measured at 550 nm using a microplate reader (Syn-
ergy, BioTek, USA). The results were generated from three
independent experiments. Each experiment was performed in
triplicate. The percentage of cytotoxicity compared to the
untreated cells was determined. Further, MTT assay was per-
formed with six narrow ranges of concentrations (i.e. 800 lg/ml,
700 lg/ml, 600 lg/ml, 500 lg/ml, 400 lg/ml and 300 lg/ml) for
the determination of IC50 value (concentration at which 50%
cell proliferation inhibited).
2.4. Experimental design
To analyze the oxidative stress, MCF-7 cells were exposed to
either OA extract (300 lg/ml) or doxorubicin (50 lM), includ-
ing negative control for a period of 12 and 24 h. Further, to
study the antioxidant potential, cells were treated with
biologically safe concentrations (50, 100 and 150 lg/ml) of
extract before 1 h, then were subjected to receive doxorubicin
(50 lM) for 12 and 24 h. At the end of the exposure, reactive
oxygen species (ROS) generation, lipid peroxidation (LPO),
superoxide dismutase (SOD) and glutathione (GSH) levels
were determined.
2.5. Intracellular reactive oxygen species (ROS) measurement
The generation of intracellular ROS was monitored using 2,7-
dichloroﬂuorescin diacetate dye (DCFH-DA) (Wang and
Joseph, 1999). The DCFH-DA passively enters the cell where
it reacts with ROS to form the highly ﬂuorescent compound
dichloroﬂuorescein (DCF). For the quantitative estimation
of intracellular ROS by spectroﬂuorometry, 1 · 104 cells per
well were seeded in 96-well culture plates (black-bottomed)
and allowed to grow for overnight in a CO2 incubator at
37 C. Then, cells were treated as mentioned above for 12
and 24 h at 37 C. At the end of respective treatment period,
cells were washed twice with PBS and then incubated with
20 lM working solution of DCFH-DA in serum free medium
at 37 C for 30 min. The reaction mixture was discarded and
replaced by 100 lL of PBS in each well. The green ﬂuorescence
intensity was detected using a Synergy microplate reader (Bio-
Tek, Winooski, VA, USA) at an excitation wavelength of
485 nm and an emission wavelength of 528 nm. The values
were averaged from multiple wells and expressed as percent
of ﬂuorescence intensity relative to the control wells.
2.6. Lipid peroxidation assay
The level of membrane lipid peroxidation was estimated by
measuring the formation of malondialdehyde using the
method of Ohkawa et al. (1979). Malondialdehyde (MDA) isone of the products of membrane lipid peroxidation. Brieﬂy,
MCF-7 cells at a ﬁnal density of approximately 1 · 105 in a
25 cm2 culture ﬂask were grown for overnight and exposed
to OA extract and doxorubicin either alone or in combination
as indicated above for 12 and 24 h. At the end of exposure, the
cells were washed twice with cold phosphate-buffered solution
(PBS) and collected by centrifugation. 200 ll of cell suspension
was mixed with 1 ml of chromogen mixture containing 25 mM
thiobarbituric acid, 0.5% of sodium dodecyl sulfate (w/v) and
5% acetic acid (v/v), pH 3.5. The sample mixture was incubat-
ed in boiling water for 30 min. Then it was cooled at room
temperature and centrifuged at 2500 rpm for 5 min. The absor-
bance of the supernatant was read at 534 nm against blank and
MDA standard. Lipid peroxidation was presented as relative
percent of control.
2.7. Glutathione (GSH) content
The GSH content was estimated by calorimetric method as
described earlier by Beutler et al. (1963) using a commercial
kit (Biodiagnostic) following the instructions provided in the
kit. Brieﬂy, after the respective exposure, MCF-7 cells were
scrapped and collected by centrifugation. The cell pellet was
homogenized in a cold buffer (50 mM potassium phosphate,
pH 7.5 containing 2 mm EDTA). The samples were then cen-
trifuged at 4000 rpm for 15 min at 4 C and supernatant was
collected. Then, 100 ll of supernatant was mixed with 500 ll
of trichloroacetic acid (TCA, 500 mM) and kept for 5 min at
room temperature. The above mixture was centrifuged at
3000 rpm for 15 min and 500 ll of supernatant was mixed with
1 ml buffer and 100 ll of 5,50-dithionitrobenzoic acid (DTNB,
1 mM) and incubated for 10 min at 37 C in water bath with
shaking. The absorbance of yellow color developed was read
at 405 nm using multiplate reader (Synergy, BioTek, USA).
2.8. Measurement of superoxide dismutase (SOD) level
Superoxide dismutase activity was estimated employing a
colorimetric method described by Nishikimi et al. (1972). This
assay relies on the ability of the enzyme to inhibit the phena-
zine methosulfate mediated reduction of nitroblue tetrazolium
dye. Brieﬂy, after the respective exposure, MCF-7 cells were
scrapped and collected by centrifugation. The cell pellets were
lysed in cell lysis buffer containing 20 mM Tris–HCl (pH 7.5),
150 mM NaCl, 1 mM Na2EDTA, and 1% Triton X-100. The
cells were centrifuged at 12,000 rpm for 10 min at 4 C. Then,
100 ll of supernatant was mixed with 1 ml of the assay mixture
that contained 50 mM phosphate buffer, 1 mM nitroblue
tetrazolium, 1 mM reduced NADH. Finally, the reaction was
initiated by adding 100 ll phenazine methosulfate (0.1 mM)
and increase in absorbance was measured at 560 nm for
5 min. The results were presented as relative percent of control.
2.9. UPLC–MS based chromatographic proﬁling
Ultra Performance Liquid Chromatography–Mass Spec-
trometry (UPLC–MS) is an advanced technique for plant
metabolite proﬁling. It allows the identiﬁcation and quantiﬁca-
tion of a large range of common plant metabolites in a single
chromatogram. Therefore, to explore the types of metabolites
that could be present; the OA extract was screened through
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(ESI) interface (Waters, Manchester, UK). The screening
was performed in both positive and negative ESI mode. The
Software Masslynx 4.1 was used for data acquisition.
2.10. Statistical analysis
All experiments were carried out with three replicates and val-
ues are presented as mean ± standard error of mean (SEM).
Microsoft Ofﬁce Excel was used for calculation and plotting
of mean and standard deviation estimates in the graphs. The
data were statistically analyzed by Student’s t-test applying a
signiﬁcance level of p< 0.05.Figure 1 Inhibition of MCF-7 cell proliferation by crude ethanolic
concentrations of extract for 24 h, and cell viability was determined b
Figure 2 Inhibition of MCF-7 cell proliferation by crude ethanolic
concentrations of extract for 24 h, and cell viability was determined
(indicated by arrow).3. Results and discussion
In the present study, an initial screening of OA extract was
performed against human breast adenocarcinoma cells. The
percentage viability of cells was 25% at a maximum concentra-
tion of 1 mg/ml, while the lowest concentration (0.03 mg/ml)
induced 15% inhibition of cell proliferation (Fig. 1). Based
on these results, the OA extracts were subjected to IC50
determination by applying narrow range of concentrations.
The relative number of viable cells as a percentage of control
was calculated, considering the absorbance at 550 nm for
the control as 100%. The IC50 value was graphically obtained
by plotting the percentage growth inhibition against theextract of Ochradenus arabicus. Cells were treated with indicated
y the MTT assay.
extract of Ochradenus arabicus. Cells were treated with indicated
by the MTT assay. The IC50 value was estimated at 562 lg/ml
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used. The OA extracts showed cytotoxicity at IC50 value of
approximately 562 lg/ml (Fig. 2), while, doxorubicin showed
35% growth inhibition at 50 lM concentrations (data not
shown).
The MCF-7 cells were treated with either doxorubicin or
OA extract alone or in combination for 12 and 24 h respective-
ly and intracellular ROS generation was quantitatively mea-
sured by HDCF-DA assay using spectroﬂuorometry. The
results (Fig. 3) revealed that OA extract alone was insigniﬁcant
in generation of ROS while doxorubicin treatment signiﬁcantly
increased the level of ROS up to 1.34 and 1.78-fold in 12 and
24 h duration respectively. On the contrary, the simultaneous
treatment reduced signiﬁcantly (p< 0.05) the level of ROS
at 100 and 150 lg/ml. The lowest concentration of OA extractFigure 3 Percentage of DCF ﬂuorescence for detection of ROS in
doxorubicin either alone or in combination for 12 h and 24 h. Each v
*indicates signiﬁcant from Control, #indicates signiﬁcant protective ef
Figure 4 Levels of lipid peroxides in MCF-7 cells after exposure o
combination for 12 h and 24 h. Each value represents the mean ± SE o
#indicates signiﬁcant protective effects from doxorubicin.(50 lg/ml) was found not to be effective. However, the expo-
sure of OA extract signiﬁcantly prevented the ROS induced
by doxorubicin in MCF-7 cells. The potential of OA extract
on doxorubicin induced lipid peroxidation in MCF-7 cells is
summarized in Fig. 4. As shown in ﬁgure, exposure of
50 lM doxorubicin resulted in a signiﬁcant (p< 0.05) increase
in membrane lipid peroxidation of 1.33 and 1.66-fold at 12 and
24 h respectively, as compared to the control cells. While, OA
extract alone did not induce lipid peroxidation. Whereas,
co-exposure of OA extract signiﬁcantly reduced the lipid
peroxidation speciﬁcally at higher duration and concentration.
The effect of OA extract on the depletion of glutathione
induced by doxorubicin exposure is presented in Fig. 5. The
results clearly indicated that treatment with doxorubicin at
50 lM reduced the glutathione level up to 28% and 49% afterMCF-7 cells after exposure of Ochradenus arabicus extract and
alue represents the mean ± SE of three experiments (P< 0.05).
fects from doxorubicin.
f Ochradenus arabicus extract and doxorubicin either alone or in
f three experiments (P< 0.05). *indicates signiﬁcant from Control,
Figure 5 Depletion in glutathione levels in MCF-7 cells after exposure of Ochradenus arabicus extract and doxorubicin either alone or in
combination for 12 h and 24 h. Each value represents the mean ± SE of three experiments (P< 0.05). *indicates signiﬁcant from Control,
#indicates signiﬁcant protective effects from doxorubicin.
Figure 6 Levels of SOD activity in MCF-7 cells after exposure of Ochradenus arabicus extract and doxorubicin either alone or in
combination for 12 h and 24 h. Each value represents the mean ± SE of three experiments (P< 0.05). *indicates signiﬁcant from Control,
#indicates signiﬁcant protective effects from doxorubicin.
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found to be ineffective in changing the level of glutathione in
these cells. Eventually, the co-exposure of OA extract resulted
in the signiﬁcant recovery of glutathione level. The level of glu-
tathione reached up to 96% and 88% at 100 and 150, 50 lg/ml
concentration. The exposure of OA extract alone did not
induce any changes in the activity of SOD in MCF-7 cells.
While treatment with 50 lM doxorubicin signiﬁcantly reduced
the activity of SOD after 12 and 24 h, which were determined
as 65% and 43% respectively, when compared with the control
(Fig. 6). On the other hand, exposure of OA extract signiﬁcant-
ly attenuated the SOD activity that was found to increase up to
85% and 78% after 12 and 24 h, respectively.Doxorubicin is an anthracycline and potent antitumor drug
widely used in the clinic for the treatment of a broad spectrum
of cancers (Buzdar et al., 1985; Singal and Iliskovic, 1998).
However, this drug continues to pose serious concern such
as generation of ROS resulting in oxidative stress and cellular
changes. Overproduction of ROS can cause oxidative damage
to biomolecules (lipids, proteins, DNA) (Uttara et al., 2009).
In the present study, doxorubicin increased signiﬁcantly ROS
level which leads to the changes in oxidative stress biomarkers
in MCF-7 cells. However, the simultaneous treatment of
MCF-7 cells with different concentrations of OA extract
decreased the ROS generation and MDA level which is a
biomarker of lipid peroxidation. Moreover, the levels of the
Figure 7 UPLC–MS spectrum obtained by screening of ethanolic extract of Ochradenus arabicus in Ve and +Ve ESI mode.
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oxidant enzymes, superoxide dismutase, were elevated as com-
pared to doxorubicin treatment alone. These ﬁndings conﬁrmed
the antioxidant potential of OA extract in MCF-7 cells that could
be attributed to the presence of major ﬂavonoids such as
kaempferol, quercetin, isorhamnetin and luteolin (Barakat
et al., 1991; Cristea et al., 2003; Moiteiro et al., 2008; Marques
et al., 2009; Berrehal et al., 2010; Villela et al., 2011). The majority
of natural antioxidants are polyphenols including ﬂavonoids,
which exhibit strong antioxidant activity by acting as free radical
scavengers, hydrogen donors, singlet oxygen quenchers, and
metal ion chelators, in addition to inducing gene expressions of
antioxidant enzymes (Krinsky, 1992; Rice-Evans, 2001).
The OA extract was diluted and ﬁltered through a 0.22 lm
PVDF syringe ﬁlter (Membrane Solutions, Texas, USA)
before being injected into the UPLC–MS system. The spec-
trum obtained by direct infusion (both in ESI +Ve and –Ve
mode) of OA extract is shown in Fig. 7. The major peaks in
the –Ve mode were observed at m/z ratio of 97.26, 115.49,
570.61 and 572.56 while in the +Ve mode a peak at m/z ratio
of 104.52 was evident. Identiﬁcation of the compounds could
be done with the aid of (m/z) ratio evaluation of the resulting
data by searching against the spectral library.
So far the identiﬁcation of candidate having anticancer
potential from the arid ﬂoristic biodiversity of the Arabian gulf
region in general is concern; the exhaustive survey of literature
reveals that there are such limited documentation (Amin and
Mousa, 2007; Mothana et al., 2009), and wild plant of Saudi
Arabia in particular have previously been poorly exploredexcept some latest reports on some medicinal and wild
plants (Almehdar et al., 2012; Elkady, 2013; Ali et al., 2014),
and the perusal of literature also reveals that O. arabicus
have not been previously included in any plant bioprospecting
program for biological activity elsewhere. In Conclusion, for
the ﬁrst time we have shown that ethanolic extract of
O. arabicus is moderately toxic to the MCF-7 cells and
conﬁrmed its antioxidant potential. However, further
investigations on O. arabicus as a potential chemotherapeutic
agent are needed.
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